- Home
- ABBV vs AXP Comparison
ABBV vs AXP Comparison
Compare ABBV & AXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABBV | AXP |
|---|---|---|
| Founded | 2012 | 1850 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 246.7B |
| IPO Year | 2012 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ABBV | AXP |
|---|---|---|
| Price | $245.90 | $340.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 16 |
| Target Price | $253.71 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 4.0M | 2.8M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.39% | 1.20% |
| EPS Growth | N/A | ★ 9.78 |
| EPS | 2.42 | ★ 8.81 |
| Revenue | ★ $61,160,000,000.00 | $27,819,000,000.00 |
| Revenue This Year | $11.87 | $19.81 |
| Revenue Next Year | $8.12 | $8.80 |
| P/E Ratio | $100.76 | ★ $38.89 |
| Revenue Growth | 8.57 | ★ 13.44 |
| 52 Week Low | $190.75 | $290.97 |
| 52 Week High | $267.47 | $387.49 |
Technical Indicators
Market Signals| Indicator | ABBV | AXP |
|---|---|---|
| Relative Strength Index (RSI) | 44.59 | 50.56 |
| Support Level | $243.07 | $333.83 |
| Resistance Level | $263.35 | $367.58 |
| Average True Range (ATR) | 5.95 | 6.45 |
| MACD | -2.59 | -0.38 |
| Stochastic Oscillator | 10.09 | 62.24 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. It operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.